"Diabetic Angiopathies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
VASCULAR DISEASES that are associated with DIABETES MELLITUS.
Descriptor ID |
D003925
|
MeSH Number(s) |
C14.907.320 C19.246.099.500
|
Concept/Terms |
Diabetic Angiopathies- Diabetic Angiopathies
- Angiopathies, Diabetic
- Angiopathy, Diabetic
- Diabetic Angiopathy
- Diabetic Vascular Diseases
- Diabetic Vascular Disease
- Vascular Disease, Diabetic
- Vascular Diseases, Diabetic
- Diabetic Vascular Complications
- Diabetic Vascular Complication
- Vascular Complication, Diabetic
- Vascular Complications, Diabetic
Microangiopathy, Diabetic- Microangiopathy, Diabetic
- Diabetic Microangiopathies
- Diabetic Microangiopathy
- Microangiopathies, Diabetic
|
Below are MeSH descriptors whose meaning is more general than "Diabetic Angiopathies".
Below are MeSH descriptors whose meaning is more specific than "Diabetic Angiopathies".
This graph shows the total number of publications written about "Diabetic Angiopathies" by people in this website by year, and whether "Diabetic Angiopathies" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 0 | 2 | 2 |
1997 | 0 | 2 | 2 |
2000 | 2 | 0 | 2 |
2002 | 0 | 1 | 1 |
2004 | 0 | 1 | 1 |
2005 | 1 | 1 | 2 |
2006 | 1 | 0 | 1 |
2008 | 1 | 0 | 1 |
2009 | 1 | 0 | 1 |
2011 | 3 | 0 | 3 |
2012 | 4 | 0 | 4 |
2013 | 2 | 0 | 2 |
2016 | 2 | 0 | 2 |
2017 | 0 | 1 | 1 |
2018 | 1 | 0 | 1 |
2019 | 1 | 1 | 2 |
2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Diabetic Angiopathies" by people in Profiles.
-
Revascularizations and limb outcomes of hospitalized patients with diabetic peripheral arterial disease in the contemporary era. J Vasc Surg. 2023 04; 77(4):1155-1164.e2.
-
Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial. Diabetes Care. 2020 02; 43(2):446-452.
-
Diabetic microcirculatory disturbances and pathologic erythropoiesis are provoked by deposition of amyloid-forming amylin in red blood cells and capillaries. Kidney Int. 2020 01; 97(1):143-155.
-
Incremental risk of cardiovascular disease and/or chronic kidney disease for future ASCVD and mortality in patients with type 2 diabetes mellitus: ACCORD trial. J Diabetes Complications. 2019 07; 33(7):468-472.
-
Baseline characteristics and enrichment results from the SONAR trial. Diabetes Obes Metab. 2018 08; 20(8):1829-1835.
-
Results of ACCORDIAN in ACCORD with lower blood pressure begetting lower mortality in patients with diabetes. Diabetes Obes Metab. 2018 06; 20(6):1335-1336.
-
Linking diabetic vascular complications with LncRNAs. Vascul Pharmacol. 2019 03; 114:139-144.
-
High-sensitivity C-reactive protein, low-density lipoprotein cholesterol and cardiovascular outcomes in patients with type 2 diabetes in the EXAMINE (Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care) trial. Diabetes Obes Metab. 2018 03; 20(3):654-659.
-
Longitudinal trends and predictors of statin use among patients with diabetes. J Diabetes Complications. 2018 01; 32(1):27-33.
-
Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: The EXAMINE trial. Diabetes Obes Metab. 2017 05; 19(5):664-671.